Expoint - all jobs in one place

ื”ืžืงื•ื ื‘ื• ื”ืžื•ืžื—ื™ื ื•ื”ื—ื‘ืจื•ืช ื”ื˜ื•ื‘ื•ืช ื‘ื™ื•ืชืจ ื ืคื’ืฉื™ื

ื“ืจื•ืฉื™ื ื‘-Msd ื‘-South Africa

ื”ืฆื˜ืจืคื• ืœื—ื‘ืจื•ืช ื”ืžื•ื‘ื™ืœื•ืช Msd ื‘South Africa ืขื ืืงืกืคื•ื™ื ื˜! ื‘ื•ืื• ืœื”ื™ื—ืฉืฃ ืœื”ื–ื“ืžื ื•ื™ื•ืช ืขื‘ื•ื“ื” ื‘ืชืขืฉื™ื™ืช ื”ื”ื™ื™ื˜ืง ื•ืœืงื—ืช ืืช ื”ืงืจื™ื™ืจื” ืฉืœื›ื ืฆืขื“ ืื—ื“ ืงื“ื™ืžื”. ื”ื™ืจืฉืžื• ืขื›ืฉื™ื• ื›ื“ื™ ืœืงื—ืช ืืช ื”ืงืจื™ื™ืจื” ืฉืœื›ื ืฆืขื“ ืื—ื“ ืงื“ื™ืžื”.
ื—ื‘ืจื” (1)
ืื•ืคื™ ื”ืžืฉืจื”
ืงื˜ื’ื•ืจื™ื•ืช ืชืคืงื™ื“
ืฉื ืชืคืงื™ื“
South Africa
ืขื™ืจ
ื ืžืฆืื• 3 ืžืฉืจื•ืช
30.06.2024
MSD

MSD Specialist - Regulatory Affairs Pharmacist South Africa, Gauteng

Limitless High-tech career opportunities - Expoint
ืชื™ืื•ืจ:
Study dossiers from the parent company in EU and US, and non-standardised formats, prior to compiling registration documents for submission to the respective S.A. and foreign regulatory authorities. This includes...
ืคืจื˜ื™ ื”ืžืฉืจื” ื”ืžืœืื™ื
30.06.2024
MSD

MSD Clinical Operations Manager Trial Agreements & Budgets South Africa, Gauteng

Limitless High-tech career opportunities - Expoint
ืชื™ืื•ืจ:
Ownership of country and site budgets. Development, negotiation and completion of Clinical Trial Research Agreements (CTRA). Oversees and tracks clinical research-related payments. Payment reconciliation at study closeout. Oversees FCPA, DPS/OFAC,...
ืคืจื˜ื™ ื”ืžืฉืจื” ื”ืžืœืื™ื
29.06.2024
MSD

MSD Therapeutic Area Head South Africa, Gauteng

Limitless High-tech career opportunities - Expoint
ืชื™ืื•ืจ:
Will lead 1 or several therapeutic areas of the growing portfolio in South Africa and Africa. Accountable for the successful execution, enrollment and quality of their clinical trial portfolio. Accountable...
ืคืจื˜ื™ ื”ืžืฉืจื” ื”ืžืœืื™ื
ื”ื’ื™ืข ื”ื–ืžืŸ ืœืคืชื— ื”ื–ื“ืžื ื•ื™ื•ืช ืงืจื™ื™ืจื” ื—ื“ืฉื•ืช ื‘ื”ื™ื™ื˜ืง ืขื Expoint! ื”ืคืœื˜ืคื•ืจืžื” ืฉืœื ื• ืžืฆื™ืขื” ื—ื™ืคื•ืฉ ืžืงื™ืฃ ืฉืœ ืžืฉืจื•ืช ื‘ื—ื‘ืจืช Msd ื‘South Africa. ืžืฆืื• ืืช ื”ื–ื“ืžื ื•ื™ื•ืช ื”ืขื‘ื•ื“ื” ื”ื˜ื•ื‘ื•ืช ื‘ื™ื•ืชืจ ื‘ืื–ื•ืจื›ื ื•ืงื—ื• ืืช ื”ืงืจื™ื™ืจื” ืฉืœื›ื ืœืฉืœื‘ ื”ื‘ื. ื”ืชื—ื‘ืจ ืœืืจื’ื•ื ื™ื ืžื•ื‘ื™ืœื™ื ื•ื”ืชื—ืœ ืืช ืžืกืข ื”ื”ื™ื™ื˜ืง ืฉืœืš ืขื Expoint. ื”ื™ืจืฉืžื• ืขื•ื“ ื”ื™ื•ื ื•ืžืฆืื• ืืช ืงืจื™ื™ืจืช ื”ื—ืœื•ืžื•ืช ืฉืœื›ื ืขื ืืงืกืคื•ื™ื ื˜.